Henrik Biverstal
Huddinge, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Response to the Letter to the Editor on "γ-Secretase modulation and plaque regression in Alzheimer's disease".
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 12, 2025
γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 27, 2024
Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS.
Journal: Protein science : a publication of the Protein Society
Published: January 24, 2024
Pro-resolving lipid mediator reduces amyloid-β42-induced gene expression in human monocyte-derived microglia.
Journal: Neural regeneration research
Published: October 10, 2023
Molecular Mechanisms of Amyloid-β Self-Assembly Seeded by In Vivo-Derived Fibrils and Inhibitory Effects of the BRICHOS Chaperone.
Journal: ACS chemical neuroscience
Published: April 06, 2023
Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain.
Journal: Molecular and cellular neurosciences
Published: January 11, 2023
Food protein-derived amyloids do not accelerate amyloid β aggregation.
Journal: Scientific reports
Published: September 26, 2022
Abilities of the BRICHOS domain to prevent neurotoxicity and fibril formation are dependent on a highly conserved Asp residue.
Journal: RSC chemical biology
Published: August 16, 2022
Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
Journal: ACS chemical biology
Published: July 25, 2022
Last Updated: 09/26/2026